Major life sciences organizations use BioServe’s Global Repository of human samples and molecular services to accelerate the development of new and safer drugs and diagnostics.
BioServe’s ‘biomaterial to data’ model offers one of the world’s largest commercial biorepositories and a full suite of preclinical molecular services and research tools to accelerate breakthroughs in genetics, drug discovery, biomarker research, and molecular diagnostics.
BioServe’s Global BioRepository provides leading academic and industry researchers with access to over 600,000 human DNA, tissue and serum samples linked to detailed clinical and demographic data from 120,000 consented and anonymized patients on four continents.
Utilizing BioServe’s preclinical molecular services, researchers can identify genetic markers, validate drug targets and correlate clinical and molecular data to accelerate the development of new and safer drugs.
BioServe’s customers include nearly every major pharmaceutical and biotechnology company, as well as top industry, academic, and government research institutions.
Founded in 1989, BioServe has corporate headquarters in Beltsville, Maryland, USA.
3 ways BioServe makes procuring high quality samples the easiest part of the development process.
Unrivaled access to clinical grade, data rich, IRB approved human samples:
In-House Samples: BioServe Global BioRepository
BioServe’s Global BioRepository is one of the largest commercial human tissue banks in the world. With more than 600,000 human tissue, serum, DNA, and RNA samples, from over 120,000 patients on four continents. There is a good chance that the samples you need are already stored in the BioRepository.
Partner Samples: The BioServe Network
The BioServe Network links together many of the industry’s leading biorepositories to help ensure you can get the samples you need.
Prospective Sample Collections
Through BioServe’s orphan disease network, rare human samples are finally within reach. BioServe continues to establish procurement partnerships with specialty clinics around the United States in a number of indications/diseases, including Autoimmune, Inflammatory and Rheumatology, Urology and Oncology.
Molecular Services Overview
Accelerating breakthroughs in genetics, drug discovery, biomarker research, and molecular diagnostics.
BioServe offers a full suite of accurate and cost-effective preclinical molecular services both as a complement to our Global BioRepository and as a stand-alone business.
BioServe has 20 years of experience with validated laboratory protocols to ensure accurate results with timely turnaround times.
Here’s a snapshot of BioServe’s current services:
Our in-house expertise in assay design, oligonucleotide synthesis and SNP validation enable us to deliver accurate data, quickly and cost-effectively. We specialize in smaller to mid-size projects, providing intense customer service from assay design to data delivery and discussing your experiment results.
DNA and RNA Extraction
We have 20 years of experience with genomic DNA and RNA isolation from nearly all biomaterials. Samples are quantitated by optical density. Quality of DNA is determined through electrophoresis. RNA quality control checks are performed through Agilent’s Bioanalyzer.
Gene Expression and Allelic Discrimination (RT PCR)
Real-time PCR measures amplification cycle-by-cycle enables quantitative measurements during the exponential phase of PCR. We now utilize latest in the family of real-time PCR instruments by Applied BioSystems – the ViiA7™.
Molecular Diagnostic Testing (CLIA Certified)
CLIA certified molecular diagnostic tests utilizing FDA approved GenMark Dx Tm platform.